2. část - pátek

Transcription

1

2 PROGRAM: čtvrtek :00-09:15 Ondrej Držík, BARIA s.r.o. Úvodní slovo 09:15-09:45 Tomáš Soukup, Department of Histology and Embryology, Faculty of Medicine in Hradec Králové, Charles University SYMBIOSIS: Assistive Devices and Mesenchymal Stem Cells 09:45-10:30 Vladimír Holáň, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, v.v.i., Stem cells in ocular surface reconstruction 10:30-11:00 Radek Špíšek, SOTIO, Charles University, 2nd Medical School and University Hospital Motol, Department of Immunology Dendritic cell-based immunotherapy of the prostate cancer 11:00-11:30 Coffee Break 11:30-12:00 Eva Matějková, National Tissue Centre Inc. Issues in Advanced Therapy Medicinal Product Development 12:00-12:45 Sylvie Bailly, Corning Corning s innovative solutions for production of advanced therapy medicinal products (ATPM) 12:45-14:45 Lunch + Poster Section 14:45-15:00 Ján Vojtaššák, Institute of Medical Biology, Genetics and Clinical Genetics, School of Medicine, Bratislava The use of Autologous Mesenchymal Stem Cells for Bone Augmentation in Orofacial Surgery 15:00-15:30 Čestmír Altaner, Institute of Experimental Oncology, Slovak Academy of Sciences Characterization of Mesenchymal Stem Cells of No-Options Patients with Critical Limb Ischemia Treated by Autologous Bone Marrow Mononuclear Cells 15:30-15:50 Marie Kalbáčová, Institute of Inherited Metabolic Disorders, Charles University in Prague, First Faculty of Medicine Cryopreservation of cells under FBS-free conditions 15:50-16:20 Coffee Break 16:20-16:50 Daniel Smrž, Institute of Immunology, 2nd Medical School and University Hospital Motol, Charles University, Cytoskeleton rearrangement in human mast cells a new role for stem cell factor in mast cell anaphylactic responses 16:50-17:20 Ján Kyselovič, Faculty of Pharmacy, Comenius University in Bratislava, Impact of patient medication on the cells therapy

3 PROGRAM: 2. část - pátek :00-09:30 Robert Dobrovolný, Institute of Inherited Metabolic Disorders, Charles University in Prague, First Faculty of Medicine Induced pluripotent stem cells as a cellular model for inborn errors of metabolism 09:30-10:00 Jan Motlík, Institute of animal physiology and genetics, Academy of Sciences of the Czech Republic, v.v.i. Transgenic minipigs for the N-terminal part of human huntingtin: a biomedical model of neurodegenerative diseases 10:00-10:30 Bernd Leistler, Cellgenix, Media and Cytokines for Ex Vivo Cell Culture 10:30-11:00 Coffee Break 11:00-11:30 Lucie Kučerová, Miroslava Matúšková, Cancer research institute, Slovak academy of sciences MSC and Cancer - Two Sides of One Coin 11:30-12:00 Discussion

4 POSTEROVÁ SEKCE: Role of HIF-1- in selfrenew and differentiation of neurospheres derived from embryonic stem cells Pánská V. 1,Večeřa J. 1, Kubala L. 2,3, Pacherník J. 1,3 Institute of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic 1 Institute of Biophysics ASCR v.v.i., Brno, Czech Republic 2 ICRC - CBCE, FNUSA, Brno, Czech 3 The role of ATP-binding transporters associated with multi-drug resistance in stem cells Lánová M., Večeřa J., Kučera J., Procházková J., Pacherník J. Přírodovědecká fakulta Masarykovy univerzity Recruitment of Oct4 protein to UV-damaged chromatin in embryonic stem cells Bártová E., Stixová L., Franek M., Kozubek S., Legartová S. Biofyzikální ústav AV ČR Surface antigen CD26 as a marker for purification of CML stem cells Borský M., Némethová V., Rázga F., Mayer J., Ráčil Z. Fakultní nemocnice Brno A novel tool for induction of specific T cell immune responses: Complexes of streptavidin-fused antigen with biotinylated antibodies targeting endocytic receptors of antigen presenting cells Staněk O., Majlessi L., Linhartová I., Leclerc C., Šebo P. Mikrobiologický ústav, AV ČR, v.v.i. Expression of the stem cell marker nestin in leukemia cells Loja T. 1,2, Borský M. 1, Bernard T. 1, Doubek M. 1,2 Department of Internal Medicine Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Czech Republic 1 CEITEC Central European Institute of Technology, Masaryk University, Czech Republic 2 Mitochondrial Morphology in Cultured Cells with Mutation in TMEM70 gene Sládková J. 1, Kratochvílová H. 1, Rodinova M. 1, Chernyavskiy O. 2, Čapek M. 2, Radochová B. 2 Department of Pediatrics and Adolescent Medicine, 1st Faculty of Medicine, Charles University in Prague and General University Hospital in Prague 1 Department of Biomathematics, Institute of Physiology Academy of Sciences of the Czech Republic 2 Institute of Cellular Biology and Pathology 1st Faculty of Medicine, Charles University Prague, Czech Republic L. 3

5 A mouse model of Fabry disease: Utilization of induced pluripotent stem cells to obtain disease relevant cell types (cardiomyocytes) Rybová J., Dobrovolný R., Ledvinová J. Ústav dědičných metabolických poruch Haematopoiesis in vitro under HIF-1 modulation Hanáčková M., Štefková K., Kubala L., Pacherník J. Masaryk University, Faculty of Science Cell adhesion and further cell fate on different carbon materials in the presence or absence of fetal bovine serum Verdánová M., Brož A., Rezek B., Ukraintsev E., Kromka A., Babchenko O., Kalbáčová M. Ústav dědičných metabolických poruch 1.LF UK a VFN v Praze Hematopoiesis of mouse embryonic stem cells - the role of p38alpha kinase Štefková K., Hanáčková M., Kučera J., Kubala L., Pacherník J. Masaryk University Exposure of colon cancer-derived HT-29 cells to 5-Fluorouracil alters their response to chemotherapeutics and MSC-mediated enzyme/prodrug treatment Ďuriníková E., Kozovská Z., Kučerová L., Matúšková M. Ústav experimentálnej onkológie SAV Prodrug gene therapy mediated by mesenchymal stem cells leads to complete regression of glioblastoma in a preclinical study Cihova M., Altanerova V., Altaner C., Mravec B., Ondicova K. Ústav experimentálnej onkológie SAV ABSTRAKTA JSOU UVEŘEJNĚNA NA